According to Future Market Insights research, during the projected forecast period, the Beta-Glucanase market is expected to grow at a CAGR of 6.3%. The market value projected to increase is from USD 387.7 Million in 2022 to USD 714.1 Million by 2032. The Beta-Glucanase market was valued at USD 369.2 Million at the end of 2021 and is anticipated to exhibit Y-o-Y growth of 5% in 2022.
| Attributes | Details |
|---|---|
| Market Size Value in 2022 | USD 387.7 Million |
| Market Forecast Value in 2032 | USD 714.1 Million |
| Global Growth Rate (2022 to 2032) | 6.3% CAGR |
| Forecast Period | 2022 to 2032 |
| USA market share of Beta-Glucanase | 33.7% |
A novel substance called beta-glucanase is currently being introduced to the market. It is a nutritional supplement produced from yeast cell walls. According to some research, beta-glucanase is good for the heart and can lower the chance of developing heart disease. Clinical testing of the product has shown that it effectively lowers levels of harmful cholesterol.
In the Historical outlook of the Beta-Glucanase market, the value increased from USD 303.7 Million in 2017 to USD 369.2 Million in 2021. The CAGR (2017 to 2021) is observed to be 5%.
A number of market factors, including the shift in consumer preferences toward veganism or plant-based foods, the increase in public health consciousness, and the availability of nutritious food products, are predicted to contribute to beta glucanase's expected positive growth. Beta-glucanase is now more accessible and more widely consumed, and the technology used to extract and process beta-glucanase has advanced, which will accelerate the expansion of this market sector.
Beta-glucanase, probiotics, and DHA are associated with reduced respiratory infections and allergy symptoms, there is a noticeable increase in demand for healthful foods and beverages that contain these ingredients in the USA. Major rivals from other regions are entering the USA market as a result of the rising demand for beta-glucanase from a number of applications.
The beta-glucanase market is projected to have high demand among consumers aged 19 to 55 due to Millennials' propensity for organic products and growing preference for clean-label food items. Beta-glucanase from yeast and algae has also been demonstrated to be a versatile substance that supports and strengthens the immune system.
The USA contributes 33.7% of the total revenue for the Beta-Glucanase Market.
Increased incidences of coronary heart disease, diabetes, and obesity are driving the market growth for beta-glucanase in the United Kingdom and will do so for the duration of the forecast period.
According to the European Food Safety Authority (EFSA), regularly consuming beta-glucanase lowers the risk of heart disease by maintaining normal blood cholesterol levels. The region's demand for the product is increasing as beta-glucanase nutritional supplements gain popularity. In the coming years, beta-glucanase demand is anticipated to rise as a result of the cosmetic industry's drive to create toxic-free cosmetics and the increased desire for natural skincare ingredients.
UK CAGR for the Beta-Glucanase market over the forecast period is 5.3%.
The APAC region's fastest economic growth is being attributed to China, where the demand for beta-glucanase is rising as a result of shifting lifestyle preferences and a booming dairy industry.
Consumers in China are becoming more aware of the health advantages of functional foods; in the upcoming years, demand for beta-glucanase will be driven by the disposable economy as well as an increase in the need for a diet high in protein and with energy-boosting capabilities.
China is a market driver in Asia Pacific and the latest CAGR in the Beta-Glucanase market is 4.6%.
From the Oceania region, Australia is contributing 2.7% of the total revenue of the Beta-Glucanase market.
Because beta-glucanase is extremely soluble, manufacturers can create products with a smooth feel. Soluble beta-glucanase is commonly used in the cosmetics industry to create skincare products because it may be easily absorbed and used by the skin to deliver the necessary aesthetic or dermatologic advantages. Companies are now offering soluble beta-glucanase, which is suited for a range of uses because it dissolves better in water than insoluble beta-glucanase.
PromOat Beta Glucanase, for instance, is a chemical-free soluble type of oat bran fiber that is made from whole grain oats and is offered by Tate & Lyle. It's excellent water-binding, emulsifying, and water-solubility properties give it a creamy, smooth texture in soups, dairy products, dressings, beverages, and sauces.
Recently, glucose polymer has gained a lot of attention as a fiber that can be found in and isolated from the cell walls of many cereals and grains, including barley and oats. The beta Glucanase found in grains and cereals is recognized to provide a number of health advantages. The ability to regulate blood cholesterol levels is one of the main advantages.
The biggest sources of beta-glucanase are thought to be barley and oats, and beta-glucanase is thought to be abundantly found in grains. They have well-known high beta-glucanase content. Beta glucanase keeps the body healthy and supports the maintenance of the digestive system, particularly the intestinal tract. Low cost and easy access to grains and cereals are further factors in the market segment's explosive expansion.
Increased demand for healthy foods and supplements as a result of a change in consumer behavior has led to new functional, organically manufactured, and non-genetically modified food products being introduced by a number of providers. As a result, as individuals become more concerned with their health and fitness, it is projected that the market for multi-functional beta-glucanase would expand in the coming years.
The mushroom is a fantastic remedy for serious disorders including cancer, AIDS, and skin issues because of its anti-cholesterol, anti-allergic, and anti-tumor properties. Mushrooms are a promising option for nutraceutical and pharmaceutical uses because their soluble fiber aids in the prevention of cardiovascular diseases. The beta-glucanase market may experience further growth as a result of the expanding use of Shiitake mushrooms to increase mucosal barrier resistance to inflammation and stop the development of intestinal ulcers.
The market's leading players have been engaging in tactics including product innovation, mergers, acquisitions, collaborations, production expansions, and geographic expansions, which have helped them to establish a prestigious position in the industry. The main players in the global beta-glucanase market use product innovation as their primary tactic.
In recent years, there has been a significant investment in Research and Development, which has resulted in the introduction of several new items to the market. A few other key tactics used by market participants include collaborations with distributors, financial support and collaboration with universities for using their research resources, and agreements with government research institutions under development programs.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value and Units for Volume |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Segments Covered |
|
| Key Companies Profiled |
|
| Report Coverage | Drivers, Restraints, Opportunities and Threats Analysis, Market Forecast, Company Share Analysis, Market Dynamics and Challenges, Competitive Landscape, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global Beta-Glucanase market will reach a valuation of USD 387.7 Million by the end of 2022.
The USA Beta-Glucanase Market is contributing 33.7% of total market share which values at USD 130.6 Million.
USA, Canada, Germany, UK, France, Russia, China, Japan, Netherlands, Norway, Australia are the major countries driving demand for Beta-Glucanase Market.
The Germany Beta-Glucanase Market is contributing 28.2% of total market share which values at USD 109.3 Million.
• Cargill Inc (USA) • Kerry Group Plc (Ireland) • AIT Ingredients (France) • Ohly GmbH (Germany) • Biorigin Zilor (Brazil) Above are the top 5 market players in Beta-Glucanase industry.
The Japan Beta-Glucanase market contribution is 11.1% of total market share.
The India Beta-Glucanase market will grow at 4.5% CAGR between 2022 and 2032
The global Beta-Glucanase market is forecasted to surpass USD 714.1 Million by the end of 2032.
Beta-Glucanase Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
